scholarly journals Application of transesophageal echocardiography for localization in totally implantable venous access port implantation through subclavian approach in children

2020 ◽  
Author(s):  
Shujun Yang ◽  
Xiangru Kong ◽  
Lifei Liu ◽  
Ying Xu ◽  
Jun Zhang
Keyword(s):  
Transesophageal Echocardiography ◽  
Venous Access ◽  
Access Port ◽  
Port Implantation ◽  
Venous Access Port

Impact of hypnosis on patient experience after venous access port implantation

2019 ◽  
Vol 38 (6) ◽  
pp. 609-613 ◽  
Author(s):  
Laura Hoslin ◽  
Cyrus Motamed ◽  
Axel Maurice-Szamburski ◽  
Clemence Legoupil ◽  
Stephanie Pons ◽  
...  
Keyword(s):  
Patient Experience ◽  
Venous Access ◽  
Access Port ◽  
Port Implantation ◽  
Venous Access Port

Late complications associated with totally implantable venous access port implantation via the internal jugular vein

2019 ◽  
Vol 28 (6) ◽  
pp. 2761-2768 ◽  
Author(s):  
Shigeaki Tsuruta ◽  
Yasutomo Goto ◽  
Hideo Miyake ◽  
Hidemasa Nagai ◽  
Yuichiro Yoshioka ◽  
...  
Keyword(s):  
Internal Jugular Vein ◽  
Jugular Vein ◽  
Venous Access ◽  
Late Complications ◽  
Access Port ◽  
Port Implantation ◽  
Venous Access Port

The Safety Level of Total Central Venous Access Port Implantation Performed by Residents

2019 ◽  
Vol 76 (1) ◽  
pp. 182-192
Author(s):  
Teresa Schreckenbach ◽  
Indra Münch ◽  
Hanan El Youzouri ◽  
Wolf Otto Bechstein ◽  
Nils Habbe
Keyword(s):  
Central Venous Access ◽  
Venous Access ◽  
Central Venous ◽  
Safety Level ◽  
Access Port ◽  
Port Implantation ◽  
Venous Access Port

Totally Implantable Venous Access Port Systems: Implant Depth-based Complications in Breast Cancer Therapy - A Comparative Study

2021 ◽  
Vol 27 ◽  
Author(s):  
Kuo Chen ◽  
Narasimha M. Beeraka ◽  
Yuanting Gu ◽  
Jingruo Li ◽  
Mikhail Sinelnikov ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Cancer Therapy ◽  
Venous Access ◽  
Breast Cancer Patients ◽  
Breast Cancer Therapy ◽  
Access Port ◽  
Group A ◽  
Venous Access Port ◽  
Group B ◽  
Group D

Background: Totally implantable venous access port system (TIVAPS) is widely used in breast cancer therapy; TIVAPS has several associated complications depending on the depth of implantation in breast cancer (BC) patients during continuous infusional chemotherapy regimens. The purpose of this study is to find out the optimal depth of TIVAPS implantation to reduce the incidence of complications during infusional chemotherapy. Methods: This study reviewed the depth TIVAPS implantation in the internal jugular vein in 1282 breast cancer patients over a ten-year period (2009-2019), and associated complications. We segregated the patients as 5 groups: ‘Group A (depth < 4 mm), Group B (depth of 4-8 mm), Group C (depth of 8-12 mm), and Group D (depth of 12-16 mm), and Group E (depth of > 16 mm)’. Consequently, the ‘internal complications’ such as infection, venous thrombotic syndrome, catheter folding & migration, extravasation, whereas the ‘external complications’ viz., inflammation, local hematoma, local cutaneous reactions, and port exteriorization were significantly analyzed during TIVAPS implantation at different depths in BC patients. Results: Overall incidence of ‘internal complications’ such as infections, venous thrombotic syndrome, catheter folding & migration, and extravasation was comparatively lesser in Group C (8-12 mm) than Group A, Group B, Group D, and Group E, respectively. Mainly, the external complications such as inflammation Group C (8-12 mm) (p<0.01) were lesser (6.8%, 3/44 cases) than Group A, Group B, Group D, Group E. On a similar note, the local hematoma, and local cutaneous reaction, and port exteriorization were observed as ‘5% (1/20 cases), 4.2% (2/47 cases), and (3.2%, 1/31 cases)’ in Group C patients (p<0.01), which were comparatively lesser than the other groups. Conclusion: Subcutaneous implantation of TIVAPS at a depth of 8-12 mm could be preferred due to the lowest incidence of internal and external complications compared to the incidence of these complications in other groups; this depth could be referred to as the safe and convenient implantation depth for the effective delivery of chemotherapy regimen in BC patients without difficulty in transcutaneous access to the port.

Sign in / Sign up

Export Citation Format

Share Document